Risk assessment

Medication Safety Risk Assessment

Safe prescribing, supply, administration and monitoring of medicines (including stimulant Controlled Drugs) in an ADHD assessment and treatment service

For ADHD ClinicRef BS-ADH-RA-001See a sample (PDF) →
£44.99
One-off purchase · no VAT · instant download
  • Instant download after checkout
  • Editable Microsoft Word (.docx)
  • Mapped to the CQC standards
  • Optional 3-monthly updates

What's inside

This risk assessment is fully drafted and structured, ready to brand and complete for your service. It covers:

  • 1. Scope and purpose
  • 2. Legal and regulatory framework
  • 3. Risk assessment methodology
  • 4. Hazards, controls and risk rating
  • 5. Action plan
  • 6. Monitoring and review
  • Disclaimer

Legislation & standards it maps to

  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 - Regulation 12 (Safe care and treatment)
  • Misuse of Drugs Act 1971 and Misuse of Drugs Regulations 2001 (as amended)
  • Misuse of Drugs (Safe Custody) Regulations 1973 (as amended)
  • Controlled Drugs (Supervision of Management and Use) Regulations 2013
  • Human Medicines Regulations 2012 (as amended)
  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 - Regulation 17 (Good governance) and Regulation 18 (Staffing)
  • Care Quality Commission (Registration) Regulations 2009 - Regulation 18 (Notification of other incidents)
  • National Institute for Health and Care Excellence guideline NG87 (Attention deficit hyperactivity disorder: diagnosis and management)
  • Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Updates and methylphenidate/atomoxetine cardiovascular monitoring guidance

Who it applies to

All prescribers, non-medical prescribers, pharmacists, registered nurses, clinical pharmacology staff, titration coordinators, administrative and reception staff, locums and agency workers involved in the prescribing, supply, storage, administration, monitoring or reconciliation of medicines at [Organisation Name]

Glossary

Plain-English explanations of the technical terms and legislation used in this document.

Accountable Officer (Controlled Drugs)
The senior person legally responsible for the safe management and use of Controlled Drugs in an organisation.
Adverse effect
An unwanted or harmful reaction caused by a medicine.
Atomoxetine
A non-stimulant medicine used to treat ADHD.
Attention Deficit Hyperactivity Disorder (ADHD)
A condition affecting attention, activity levels and impulse control, often treated with medicines and other support.
Blood pressure (BP)
The pressure of blood in the arteries, checked to monitor heart and circulation health.
Care Quality Commission (CQC)
The independent regulator of health and social care services in England.
Centile chart
A growth chart that compares a child's height or weight against the typical range for their age.
Contraindication
A reason why a particular medicine or treatment should not be used in a specific person.
Controlled Drug (CD)
A medicine whose supply, storage and records are tightly restricted by law because of its potential for misuse.
Controlled Drug register
The legally required record of every Controlled Drug received, supplied or destroyed, with a running balance.
Controlled Drugs (Supervision of Management and Use) Regulations 2013
The law requiring organisations to manage and monitor Controlled Drugs safely and to report concerns.
Decision support
Built-in prompts and checks in a prescribing system that help clinicians prescribe safely.
Dexamfetamine
A stimulant Controlled Drug used to treat ADHD.
Diversion
The illegal movement of a prescribed medicine away from the patient it was intended for, for example through selling or sharing.
Duty of candour
The legal duty to be open and honest with a person and their family when something goes wrong with their care.
Electrocardiogram (ECG)
A simple test that records the heart's electrical activity to check for heart problems.
Formulary
An approved list of medicines that a service has agreed clinicians may prescribe.
General Medical Council (GMC)
The body that registers and regulates doctors in the United Kingdom.
General practitioner (GP)
A family doctor who provides general medical care in the community.
Guanfacine
A non-stimulant medicine used to treat ADHD.
Hard-stop
A built-in block in a computer system that prevents an action from continuing until a required step is completed.
Hazard
Anything that has the potential to cause harm.
Health and Social Care Act 2008 (Regulated Activities) Regulations 2014
The regulations setting out the fundamental standards that registered care providers must meet, enforced by the Care Quality Commission.
Human Medicines Regulations 2012
The main law governing how medicines are licensed, prescribed and supplied in the United Kingdom.
Indemnity
Insurance or cover that protects a clinician and patients against the cost of claims arising from their practice.
Information governance
The framework for handling people's personal and health information legally, securely and appropriately.
Lisdexamfetamine
A stimulant Controlled Drug used to treat ADHD.
Local Intelligence Network (LIN)
A regional group that shares information to monitor and prevent the misuse of Controlled Drugs.
Locum
A clinician who works temporarily to cover for, or add to, a service's regular staff.
Medicines and Healthcare products Regulatory Agency (MHRA)
The United Kingdom body that regulates medicines and medical devices and monitors their safety.
Medicines optimisation
Making sure each patient gets the best possible outcomes from their medicines, safely and with the least waste.
Medicines reconciliation
Checking and confirming the full, accurate list of medicines a person is taking, especially when their care moves between settings.
Methylphenidate
A stimulant Controlled Drug commonly used to treat ADHD.
Misuse of Drugs Act 1971 and Misuse of Drugs Regulations 2001
The laws controlling dangerous or harmful drugs and setting out how Controlled Drugs may lawfully be handled.
Misuse of Drugs (Safe Custody) Regulations 1973
The law setting out how Controlled Drugs must be securely stored, for example in an approved cabinet.
Modified release
A medicine formulation designed to release the drug slowly over time rather than all at once.
Monoamine oxidase inhibitor (MAOI)
A type of medicine, usually for depression, that can dangerously interact with some ADHD medicines.
Near miss
An event that could have caused harm but did not, by chance or because it was caught in time.
National Institute for Health and Care Excellence (NICE)
The body that produces evidence-based guidance on treatments and care for use across health and social care.
Nominated Individual
The senior person responsible to the regulator for supervising how a service is provided.
Non-medical prescriber
A trained health professional, such as a nurse or pharmacist, who is qualified to prescribe medicines.
Nursing and Midwifery Council (NMC)
The body that registers and regulates nurses and midwives in the United Kingdom.
Patient Group Direction (PGD)
A written instruction letting named staff supply or give a medicine without an individual prescription.
Prescription-only medicine (POM)
A medicine that may lawfully be supplied only on the instruction of an appropriate prescriber.
Proforma
A standard form used to make sure all required information is recorded consistently.
Registered Manager
The person registered with the regulator as responsible for the day-to-day running of a service.
Regulated activity
A type of care or treatment the law requires a provider to register with the regulator to deliver.
Residual risk
The level of risk that remains after existing controls and safeguards have been applied.
Risk assessment
A structured check identifying what could cause harm and what is being done to prevent it.
Royal Pharmaceutical Society
The professional body for pharmacists in Great Britain, which issues guidance on the safe handling of medicines.
Safe Custody-compliant cabinet
A storage cabinet that meets the legal security standards for keeping Controlled Drugs.
Safeguarding
Protecting people's health, wellbeing and rights and keeping them safe from abuse, harm or neglect.
Schedule 2
A legal category of Controlled Drugs subject to strict requirements for prescribing, storage and record-keeping.
Shared care
An arrangement where responsibility for a patient's treatment and monitoring is shared between a specialist service and their general practitioner.
Single assessment framework
The structure the regulator uses to judge a service, built around quality statements and five key questions (safe, effective, caring, responsive, well-led).
So far as is reasonably practicable
Doing everything sensible to reduce a risk, weighing the effort and cost against how much harm it would prevent.
Standard operating procedure (SOP)
A written step-by-step instruction setting out how a particular task must be carried out.
Stimulant
A type of medicine that increases activity in the brain and is commonly used to treat ADHD.
Titration
Gradually adjusting a medicine dose up or down to find the level that works best with the fewest side effects.

How it works

  1. Buy securely with Stripe - instant, no VAT, no account needed.
  2. Download your editable Word file from the link we email you straight away.
  3. Complete the placeholders for your service, then have it approved before use.
  4. Add the optional updates subscription and we keep it current as guidance changes.

Related documents

PolicyADHD Assessment Policy£54.99
PolicyMedication Management Policy£54.99
PolicySafeguarding Children Policy£54.99
PolicyConsent & Capacity Policy£54.99

Need the whole set?

Buy the full ADHD Clinic pack and save versus buying documents individually.

View the ADHD Clinic pack